Viewing Study NCT02742051


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2026-02-21 @ 12:30 AM
Study NCT ID: NCT02742051
Status: COMPLETED
Last Update Posted: 2021-09-23
First Post: 2016-04-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords: